Pfizer cuts 2,200 US sales reps

December 1, 2006
Sales and Marketing Pfizer, US, job cuts, salesforce

 Pfizer has announced a cut of 20% to its US salesforce, a move it says will help it adapt to …

Link Holdings bought by niche pharma company Archimedes

December 1, 2006
Sales and Marketing

Archimedes Pharma, a European niche pharma company specialising in nasal drug delivery systems, has bought the UK-based pharma group Link …

AZ sales hit by launch of generic Toprol

November 30, 2006
Sales and Marketing AstraZeneca

AstraZeneca's share prices took a dip after news that the company's end-of-year sales figures would be lower than predicted. These …

Merck to diversify its DTC marketing

November 29, 2006
Medical Communications

Merck is to spend less money on consumer television advertising in the future and increase its use of targeted media,such …

Takeover will create UK leader in pulmonary products

November 29, 2006
Research and Development, Sales and Marketing

Pulmonary product development in the UK has received a boost following the takeover by biotech company Vectura of the drug …

New blindness treatment moves closer to market

November 28, 2006
Sales and Marketing AMD, Lucentis, Novartis

Patients suffering from the leading cause of blindness could soon benefit from a new treatment after it gained preliminary approval …

Byetta receives EU approval for Type II diabetes

November 28, 2006
Sales and Marketing diabetes

Lilly and Amylin's new diabetes treatment, Byetta, has won EU approval.It is the first in a new class of anti-diabetic …

Bayer beats predictions in third quarter results

November 28, 2006
Sales and Marketing

German drug and chemicals company Bayer is forecasting full-year sales of around €30 billion for 2006, following better-than-predicted third quarter …

Can pharma help the NHS to change?

November 27, 2006
Sales and Marketing NHS, healthcare, industry relations, strategy

If there has been one constant during the 58 years of the NHS, it has been change  - continuous, relentless …

Merck looks to traditional medicine in cancer research

November 20, 2006
Research and Development

Merck is to collaborate with traditional medicine company Chi-Med to develop new small molecule anti-cancer drugs from natural products.Chi-Med, based …

A fresh perspective on your business

November 20, 2006
Sales and Marketing consultants, marketing

A consultant is someone who borrows your watch to tell you the time- a cynical view of the role of …

Sanofi-Aventis to collaborate with French biotech company on Alzheimer’s disease

November 20, 2006
Research and Development

Pharma company Sanofi-Aventis has entered into a research agreement with a major French biotech firm to study the role of …

NICE to say no to Tarceva

November 17, 2006
Sales and Marketing NICE, Tarceva

Roche's new lung cancer treatment Tarceva looks set to be refused recommendation from NICE.Tarceva (erlotinib) is the first next-generation treatment …

Future global R&D for Bayer Schering defined

November 17, 2006
Research and Development

Following the merger deal between German pharma companies Bayer and Schering earlier this year, the new corporation has unveiled radical …

Sanofi-Aventis to expand diabetes and thrombosis work with Euro RSCG

November 17, 2006
Medical Communications

Sanofi-Aventis has retained the agency Euro RSCG Life to promote two of its major brands around the world, insulin analogue …

NICE to face judicial review over Alzheimer’s drug decision

November 17, 2006

Legal action is to be taken against NICE over its decision to withdraw approval for NHS drugs for mild and …

Surprise delay for Novartis’ Galvus

November 15, 2006
Sales and Marketing Galvus, diabetes

The FDA will take three months longer than expected to review Novartis' new diabetes treatment, Galvus, after the pharma company …

Trained to win

November 13, 2006
Business Services, Sales and Marketing marketing, sales, training

Pharmaceutical sales and marketing managers have a dizzying array of training courses, educational aids and events at their disposal, all …

Genentech to buy biotech Tanox for $900 million

November 10, 2006
Sales and Marketing Genentech

 Genentech is to pay $919 million for Tanox, a biotech company which specialises in monoclonal antibodies.Genentech has been working with …

iPod-ready patient information leaflets coming soon

November 10, 2006
Sales and Marketing patients

From next month, patients will be able to learn about their medicines by listening to an iPod, MP3 player or …

The Gateway to Local Adoption Series

Latest content